tradingkey.logo

Advanced Biomed Inc

ADVB
0.284USD
-0.018-6.00%
Close 02/02, 16:00ETQuotes delayed by 15 min
6.14MMarket Cap
LossP/E TTM

Advanced Biomed Inc

0.284
-0.018-6.00%

More Details of Advanced Biomed Inc Company

Advanced Biomed Inc. is a holding company that operates, through its subsidiaries, Advanced Biomed Inc. (Taiwan) and Advanced Biomed HK Limited. The Company is engaged in the provision of assay products and services for cancer patients. These services include early screening and detection, diagnosis and staging, treatment selection, and patient outcome interventions for cancer. It has developed a microfluidic technology platform to integrate research and development, design, and manufacture of biochips and microfluidic chips. The platform combines its patented chip technology and will enable localized operations of a variety of microfluidic chips, biosensors made by semiconductor fabrication technology, and integrated application patented technology. The Company offers devices, such as A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre-Chip and AC-1000 CTC Enrichment Chip and A+CellScan Chip.

Advanced Biomed Inc Info

Ticker SymbolADVB
Company nameAdvanced Biomed Inc
IPO dateMar 06, 2025
CEO- -
Number of employees31
Security typeOrdinary Share
Fiscal year-endMar 06
Address401 Ryland St
CityRENO
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code89502
Phone1862120510823
Websitehttp://www.advanbiomed.com/
Ticker SymbolADVB
IPO dateMar 06, 2025
CEO- -

Company Executives of Advanced Biomed Inc

Name
Name/Position
Position
Shareholding
Change
Dr. I-Fang (Steven) Cheng, Ph.D.
Dr. I-Fang (Steven) Cheng, Ph.D.
Chief Technology Officer, Director
Chief Technology Officer, Director
--
--
Mr. Alan
Mr. Alan
Director of Investor Relations
Director of Investor Relations
--
--
Name
Name/Position
Position
Shareholding
Change
Dr. I-Fang (Steven) Cheng, Ph.D.
Dr. I-Fang (Steven) Cheng, Ph.D.
Chief Technology Officer, Director
Chief Technology Officer, Director
--
--
Mr. Alan
Mr. Alan
Director of Investor Relations
Director of Investor Relations
--
--

Revenue Breakdown

Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.

Shareholding Stats

Updated: Sun, Feb 1
Updated: Sun, Feb 1
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Lu (Yi Ph.D.)
31.00%
Pau (Hung To)
16.29%
Advance on Ventures Ltd
10.09%
Luo (Xiaoyuan)
6.46%
Zhu (Beili)
5.59%
Other
30.58%
Shareholders
Shareholders
Proportion
Lu (Yi Ph.D.)
31.00%
Pau (Hung To)
16.29%
Advance on Ventures Ltd
10.09%
Luo (Xiaoyuan)
6.46%
Zhu (Beili)
5.59%
Other
30.58%
Shareholder Types
Shareholders
Proportion
Individual Investor
59.33%
Corporation
10.09%
Hedge Fund
0.64%
Venture Capital
0.24%
Investment Advisor
0.18%
Research Firm
0.15%
Other
29.36%

Institutional Shareholding

Updated: Mon, Dec 8
Updated: Mon, Dec 8
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
6
262.83K
0.61%
--
2025Q3
6
262.83K
0.61%
+131.46K
2025Q2
4
131.38K
0.05%
+120.16K
2025Q1
1
11.21K
0.00%
+11.21K

Shareholder Activity

Name
Shares Held
Proportion
Change
Chg %
Date
Lu (Yi Ph.D.)
6.71M
31%
--
--
Jul 23, 2025
Pau (Hung To)
3.52M
16.29%
--
--
Jul 23, 2025
Advance on Ventures Ltd
2.18M
10.09%
--
--
Jul 23, 2025
Luo (Xiaoyuan)
1.40M
6.46%
--
--
Jul 23, 2025
Citadel Advisors LLC
139.51K
0.64%
+81.84K
+141.92%
Sep 30, 2025
XTX Markets LLC
52.23K
0.24%
+52.23K
--
Sep 30, 2025
HRT Financial LP
35.68K
0.16%
+35.68K
--
Sep 30, 2025
Virtu Americas LLC
32.05K
0.15%
+7.77K
+32.00%
Sep 30, 2025
UBS Financial Services, Inc.
3.36K
0.02%
-21.47K
-86.47%
Sep 30, 2025
View more

Related ETFs

Name
Proportion
No Data

Dividend

A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data

Stock Splits

Date
Ex-dividend Date
Type
Ratio
No Data
Date
Ex-dividend Date
Type
Ratio
No Data
KeyAI